- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04948268
Digital Mental Health Service for Non-Treatment Seeking Young Adults
This is a feasibility trial of a personalized 8-week text messaging intervention aimed at young adults (ages 18-25) with depression and anxiety who are not interested in -- or experience barriers to -- receiving traditional face-to-face psychological treatments.
The trial will consist of a pilot test of (1) an 8-week adaptive (personalized) messaging intervention relative to (2) a non-personalized digital mental health intervention, or (3) an active control which will send weekly psychoeducation information by way of Uniform Resource Locators (URLs). The adaptive intervention will uses machine learning to tailor Short Message Service (SMS) messages to an individual's needs and preferences, and URL links to provide access to psychoeducational content to contextualize messages, when the length of that content exceeds the limitations of messages.
The primary goals of the project are to conduct a feasibility trial using a sequential multiple assignment randomized treatment (SMART) design, which will evaluate (a) the effectiveness of an adaptive, personalized messaging intervention in reducing engagement relative to a non-personalized version; and (b) whether human coaching results in greater symptom reduction and engagement, relative an unguided implementation.
Study Overview
Status
Conditions
Detailed Description
The primary purpose of this trial is to test the feasibility of conducting a randomized controlled trial of digital mental health intervention (DMHI) for non-treatment seeking young adults with symptoms of depression or anxiety, comparing an 8-week adaptive (personalized) messaging intervention, an 8-week non-personalized digital mental health intervention, or an active control which will deliver psychoeducational content via clickable URLs. The adaptive intervention will be powered by reinforcement learning to deliver tailored SMS messages based on user profiles and the ways in which a user interacts with the intervention system, along with links to longer psychoeducational content. The non-personalized intervention arm will not personalize the messages, but will still be an active treatment. This study will examine the adaptive intervention's ability to engage users and effectiveness in decreasing psychological distress relative to a non-personalized intervention. Participants who become disengaged (5 continuous days of not clicking on content URL links, responding to messages, or message ratings) from the adaptive or static intervention arms at any point in the first two weeks of treatment will be randomized to receive low-intensity human coaching or continue without coaching for the remainder of the intervention period.
Recruitment will take place via Mental Health America's (MHA) website. MHA is a large mental health advocacy organization that hosts online screeners and has large number of visitors the majority of whom meet clinical cutoffs for depressive or anxiety disorder symptoms. This study will enroll individuals who have completed a depression or anxiety disorder screener on MHA's website, and meet clinical cut-offs on the Patient Health Questionnaire - 9 (PHQ-9) or Generalized Anxiety Disorder - 7 (GAD-7).
Initial randomization will be generated in permuted blocks of 5 using a computer program. To prevent allocation bias, randomization will be conducted by the biostatistician, who will not inform the study team of the treatment arms until the baseline assessment has been completed and the patient has been enrolled. Second randomization of disengaged participants will occur as disengagement is detected during the first two weeks. Half (50%) of disengaged individuals will be randomized to receive additional human coaching throughout the remainder of the study while remaining in either the adaptive or non-personalized treatment arms. The disengaged participants not randomized to receive additional human coaching will continue to receive either the non-personalized or adaptive automated treatment the participants were randomized to initially.
Coaching will consist of providing users with support and accountability via positive reinforcement, goal and expectation setting, and monitoring. Coaching outreach will focus on adherence to the treatment but will not provide treatment advice. Coaches will provide a brief (15-minute phone call or equivalent depending on the medium) engagement session over the phone, SMS, or email, depending user preference. Thereafter, coaches will check in with participants via messaging, phone call, or email, twice per week and respond to patient texts.
Participants will be assessed using self-report measures at baseline, weeks 4, 8, 12, and 16 weeks.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jonah Meyerhoff, PhD
- Phone Number: 312-503-1232
- Email: jonah.meyerhoff@northwestern.edu
Study Contact Backup
- Name: David C. Mohr, PhD
- Phone Number: 312-503-1403
- Email: d-mohr@northwestern.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Recruiting
- Northwestern University
-
Contact:
- Jonah Meyerhoff, PhD
- Phone Number: 312-503-1232
- Email: jonah.meyerhoff@northwestern.edu
-
Contact:
- David C Mohr, PhD
- Phone Number: 312-503-1403
- Email: d-mohr@northwestern.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Ages 18 to 25 *The age to provide consent in Nebraska is 19. Individuals recruited from the state of Nebraska must be 19 or older.
- A positive screen on an MHA screen for depression (Patient Health Questionnaire - 9 [PHQ-9]) or anxiety (Generalized Anxiety Disorder - 7 [GAD-7]);
- Resident of the United States.
- Owns a smartphone
Exclusion Criteria:
- Current treatment with psychotherapy or psychiatric medication management;
- Seeking or plans to seek traditional mental health treatment (psychotherapy or psychiatric medication management) in next 8 weeks;
- Serious mental illness for which intervention would be contraindicated (e.g., psychotic disorder, manic episode, etc.)
- Severe suicidality (i.e., experiencing suicidal ideation with a plan and intent to act);
- English insufficient to engage in design activities.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Adaptive digital mental health intervention without coaching
The adaptive intervention will consist of SMS messages, symptom tracking, and psychological content that centers on evidence-based psychological strategies.
Psychoeducational content will be delivered via a URL in an SMS message.
Machine learning will be used to tailor messages and timing to meet participant preferences.
|
Psychological content and messages delivered regularly over an 8-week period via interactive SMS messages.
Content and messages will be tailored using machine learning.
|
Experimental: Non-personalized digital Mental Health intervention without coaching
The non-personalized intervention will consist of SMS messages, symptom tracking, and psychological content that centers on evidence-based psychological strategies.
Messages and content will not be tailored based on participants profile or usage.
|
Psychological content and messages delivered regularly over an 8-week period via interactive SMS messages.
Psychological content will center on a single psychological strategy each week.
There will not be any tailoring of messaging and content based on group or individual level data.
|
Experimental: Adaptive digital mental health intervention with coaching
The adaptive intervention will consist of SMS messages, symptom tracking, and psychological content that centers on evidence-based psychological strategies.
Psychoeducational content will be delivered via a URL in an SMS message.
Machine learning will be used to tailor messages and timing to meet participant preferences.
Coaching will be provided to support engagement and intervention use via medium of participants choice (texts, calls, or emails).
|
Psychological content and messages delivered regularly over an 8-week period via interactive SMS messages.
Content and messages will be tailored using machine learning.
Human coaching to support intervention use and engagement via telephone calls, text or email
|
Experimental: Non-personalized digital Mental Health intervention with coaching
The non-personalized intervention will consist of SMS messages, symptom tracking, and psychological content that centers on evidence-based psychological strategies.
Messages and content will not be tailored based on participants profile or usage.
Coaching will be provided to support engagement and intervention use via medium of participants choice (texts, calls, or emails).
|
Psychological content and messages delivered regularly over an 8-week period via interactive SMS messages.
Psychological content will center on a single psychological strategy each week.
There will not be any tailoring of messaging and content based on group or individual level data.
Human coaching to support intervention use and engagement via telephone calls, text or email
|
Active Comparator: Active control
The active control condition will provide brief text messages that include a URL link to psychoeducational content, but will not include the interactive messaging component described in experimental arms.
|
SMS messages with URLs containing brief psychoeducational information.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Kessler Psychological Distress Scale
Time Frame: 16 weeks
|
10-item self-report measure of transdiagnostic distress, used as outcome measure across diagnostic categories.
Higher scores mean greater distress.
Minimum score: 10; maximum score: 50
|
16 weeks
|
Engagement length
Time Frame: Up to 16 weeks
|
Last message/content rating or click on content URL link received from participant.
|
Up to 16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Health Questionnaire-9
Time Frame: 16 weeks
|
10-item self-report measure assessing depression symptom severity.
Higher scores mean greater symptom severity.
Minimum score: 0; maximum score: 27
|
16 weeks
|
Generalized Anxiety Disorder-7
Time Frame: 16 weeks
|
8-item self-report measure assessing generalized anxiety disorder symptom severity Higher scores mean greater symptom severity.
Minimum score: 0; maximum score: 21
|
16 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Objective engagement markers
Time Frame: 16 weeks
|
Number of message & content ratings, and content URL clicks.
|
16 weeks
|
Cognitive Behavioral Response to Stress Scale
Time Frame: 16 weeks
|
9-item self-report measure of behavioral and cognitive coping related skills. Higher scores indicate greater adaptive cognitive and behavioral skills use. Two domains: Use and usefulness. For each domain, minimum score: 0; maximum score: 54 |
16 weeks
|
Depression Symptom Inventory - Suicidality Subscale
Time Frame: 16 weeks
|
4-item self-report questionnaire assessing the frequency and intensity of suicidal thoughts over previous two weeks. Higher scores signal greater frequency and severity of suicidal thoughts. Minimum score: 0; maximum score: 12 |
16 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: David C Mohr, PhD, Northwestern University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R34MH124960 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Adaptive messaging intervention
-
University of California, San FranciscoUniversity of California, Berkeley; Agency for Healthcare Research and Quality...CompletedDepression | Diabetes | Physical ActivityUnited States
-
Harvard School of Public Health (HSPH)CompletedSmoking Cessation | Smoking, Tobacco | Second Hand Tobacco SmokeUnited States
-
Johns Hopkins UniversityCompletedChronic Kidney Diseases | Communication | Adherence, MedicationUnited States
-
Washington University School of MedicineRecruitingObesity | Overweight | Severe Mental DisorderUnited States
-
University of PennsylvaniaBenefits Data TrustRecruitingSocial Determinants of HealthUnited States
-
Jonsson Comprehensive Cancer CenterWithdrawnSurvivors of Childhood CancerUnited States
-
Halmstad UniversityVinnovaCompleted
-
University of Massachusetts, WorcesterYale University; Worcester Polytechnic Institute; Michigan State UniversityNot yet recruitingMajor Depressive EpisodeUnited States
-
University of VermontNational Institute on Drug Abuse (NIDA)Completed
-
University of WashingtonJohn L. Locke Jr. Charitable TrustTerminatedMyocardial Infarction | Percutaneous Coronary Intervention | Coronary Artery Bypass Surgery | Chronic Stable Angina | Left Ventricular Assist Device | Heart Transplant | Chronic Stable Heart Failure | Heart Valve Repair or ReplacementUnited States